伊朗婴幼儿及儿童麻疹免疫状态与疫情担忧:重新考虑疫苗接种计划的时机?
该横断面研究于2022年6月至2023年1月在伊朗一家转诊医院检测969名不同年龄组受试者的麻疹IgG和IgM抗体,发现IgM阳性率23%、IgG阳性率52%,婴儿6月龄前平均IgG为477 mIU/mL、6–12月龄降至230 mIU/mL、12–18月龄升至683 mIU/mL、18–72月龄达峰值938 mIU/mL。作者认为年轻人群IgM阳性率上升提示疫情风险,考虑母体抗体下降,6–9月龄接种疫苗可能有益。
要点
- 969名受试者中麻疹IgM阳性23%(221/953),IgG阳性52%(504/969)。
- 婴儿平均IgG从6月龄前477 mIU/mL降至6–12月龄230 mIU/mL。
- 作者认为6–9月龄接种疫苗可能有益,青少年和女性加强免疫或可降低疫情风险。
核心结论
- 年轻伊朗人IgM阳性率上升提示麻疹疫情风险增加,可能与免疫空白有关。
- 婴儿抗体水平不足引发对疫苗有效性的担忧。
- 考虑母体抗体下降,6–9月龄接种婴儿可能有益,青少年和女性加强免疫或可进一步降低疫情风险。
研究设计与样本
- 横断面研究,于2022年6月至2023年1月在伊朗一家转诊医院(儿童医疗中心)开展。
- 共纳入969名不同年龄组受试者,检测血清麻疹特异性IgG和IgM抗体,并对IgG阳性及临界样本进行亲和力检测。
主要发现
- 麻疹IgM ELISA阳性率为23%(221/953),IgG ELISA阳性率为52%(504/969)。
- 麻疹病毒特异性IgG亲和力检测中,大多数(418/573,73%)显示高亲和力抗体。
- 6月龄以下婴儿平均IgG水平为477 mIU/mL,6–12月龄降至230 mIU/mL,12–18月龄显著升至683 mIU/mL,18–72月龄儿童达峰值938 mIU/mL。
临床怎么用
- 作者认为,考虑母体抗体下降,6–9月龄接种婴儿可能有益。
- 作者认为,青少年和女性加强免疫或可进一步降低疫情风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Measles vaccination has greatly reduced the disease burden worldwide, but challenges remain due to variations in vaccine effectiveness across age groups. This study aimed to assess the serological profile of measles antibodies across different age groups, evaluate the impact of maternal immunity on antibody levels in infants under 12 months, and assess measles immunity in vaccinated individuals. MATERIAL AND METHODS: This cross-sectional study was conducted from June 2022 to January 2023 at the Children's Medical Center, a referral hospital in Iran. Serum samples were tested for measles-specific IgG and IgM antibodies using a commercial enzyme-linked immunosorbent assay (ELSA). An avidity assay was performed to assess measles virus-specific IgG antibodies on the samples that were positive and borderline for the measles IgG ELISA. RESULTS: The study included 969 participants across various age groups. Among them, 23% (221 out of 953) tested positive for measles IgM ELISA, and 52% (504 out of 969) for measles IgG ELISA. Regarding the avidity assay for measles virus-specific IgG, the majority (418 out of 573, 73%) showed high-avidity antibodies. Measles-specific IgG levels varied significantly across different age groups, with infants below 6 months old showing a mean IgG level of 477 mIU/mL, declining to 230 mIU/mL between 6 and 12 months, and increasing significantly to 683 mIU/mL in the 12 to 18 month age group, reaching a peak at 938 mIU/mL among children aged 18-72 months. CONCLUSION: The increasing IgM positivity among young Iranians suggests a rising risk of measles outbreaks, possibly due to vaccination gaps. Inadequate antibody levels in infants raise concerns about vaccination effectiveness. Considering declining maternal antibodies, vaccinating infants at 6-9 months could be beneficial. Boosters for adolescents and women may further mitigate outbreak risks.
引用
- Pourakbari B, Ashraf Talesh S, Mahmoudi S, et al. Measles immunity status in Iranian infants and children and outbreak concerns: Time for reconsidering the vaccination schedule? Vaccine. 2024. PMID: 39168077. doi:10.1016/j.vaccine.2024.126243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。